1. The generic pharmaceutical industry: moving beyond incremental innovation towards re-innovation;Barei;Generics Biosimilars Initiative J (GaBI J),2014
2. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J Health Econ,2016
3. Teva Pharmaceuticals Industries Limited. NTEs: A New Pipeline ….Through Integration. ; 2015.
4. Innovation strategies for generic drug companies: moving into supergenerics;Ross;IDrugs.,2010
5. The refinement of the super generic concept: semantic challenge for product re-innovation?;Barei;Generics Biosimilars Initiative J (GaBI J),2015